Genentech

GAZYVA

Manufacturer:

Genentech

Gazyva HCPCS:

J9301

HCPCS Code Descriptor:

Injection, obinutuzumab, 10 mg

Category:

J Code

Gazyva NDCs:

50242-0070-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Gazyva CPT Codes:

Potential CPT administration codes for Gazyva can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Gazyva:

GAZYVA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9301 is aligned to the drug GAZYVA.

ACCESS PRICING AND MORE BY REGISTERING

J9301 Added Date:

January 1, 2015

J9301 Effective Date:

January 1, 2015

J9301 Termination Date:

HCPCS Active

Gazyva billing and coding information can be found through Genentech at the link below:
Gazyva patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
GAZYVA prescribing information can be found at the link below:
Information regarding GAZYVA’s side effects can be found at MedlinePlus